» Articles » PMID: 27189932

Insights into the Role of Neuronal Glucokinase

Overview
Date 2016 May 19
PMID 27189932
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Glucokinase is a key component of the neuronal glucose-sensing mechanism and is expressed in brain regions that control a range of homeostatic processes. In this review, we detail recently identified roles for neuronal glucokinase in glucose homeostasis and counterregulatory responses to hypoglycemia and in regulating appetite. We describe clinical implications from these advances in our knowledge, especially for developing novel treatments for diabetes and obesity. Further research required to extend our knowledge and help our efforts to tackle the diabetes and obesity epidemics is suggested.

Citing Articles

Hexokinase-linked glycolytic overload and unscheduled glycolysis in hyperglycemia-induced pathogenesis of insulin resistance, beta-cell glucotoxicity, and diabetic vascular complications.

Rabbani N, Thornalley P Front Endocrinol (Lausanne). 2024; 14:1268308.

PMID: 38292764 PMC: 10824962. DOI: 10.3389/fendo.2023.1268308.


Characterizing lysine acetylation of glucokinase.

Fatema N, Li X, Gan Q, Fan C Protein Sci. 2023; 33(1):e4845.

PMID: 37996965 PMC: 10731539. DOI: 10.1002/pro.4845.


Nano-Stevia reduces the liver injury caused by streptozotocin (STZ)-induced diabetes in rats by targeting PEPCK/GCK genes, INSR pathway and apoptosis.

Mousavi-Niri N, Khakpai F, Moheb-Alian M, Ghanimati E, Abdollah-Pour F, Naseroleslami M J Diabetes Metab Disord. 2023; 22(2):1519-1529.

PMID: 37975120 PMC: 10638348. DOI: 10.1007/s40200-023-01278-2.


How Do Modulators Affect the Orthosteric and Allosteric Binding Pockets?.

Chen C, Jiang C, Yuan J, Chen M, Cuyler J, Xie X ACS Chem Neurosci. 2022; 13(7):959-977.

PMID: 35298129 PMC: 10496248. DOI: 10.1021/acschemneuro.1c00749.


Potential impact of , and gene abnormalities on the development and progression of type 2 diabetes mellitus in Asir and Tabuk regions of Saudi Arabia.

Mir M, Mir R, Alghamdi M, Wani J, Elfaki I, Sabah Z Mol Med Rep. 2022; 25(5).

PMID: 35293603 PMC: 8941532. DOI: 10.3892/mmr.2022.12675.


References
1.
Borg W, Sherwin R, During M, Borg M, Shulman G . Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes. 1995; 44(2):180-4. DOI: 10.2337/diab.44.2.180. View

2.
Briski K, Sylvester P . Hypothalamic orexin-A-immunpositive neurons express Fos in response to central glucopenia. Neuroreport. 2001; 12(3):531-4. DOI: 10.1097/00001756-200103050-00020. View

3.
Wynne K, Stanley S, McGowan B, Bloom S . Appetite control. J Endocrinol. 2005; 184(2):291-318. DOI: 10.1677/joe.1.05866. View

4.
Matschinsky F, Magnuson M, Zelent D, Jetton T, Doliba N, Han Y . The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes. 2005; 55(1):1-12. View

5.
Zhu W, Czyzyk D, Paranjape S, Zhou L, Horblitt A, Szabo G . Glucose prevents the fall in ventromedial hypothalamic GABA that is required for full activation of glucose counterregulatory responses during hypoglycemia. Am J Physiol Endocrinol Metab. 2010; 298(5):E971-7. PMC: 2867375. DOI: 10.1152/ajpendo.00749.2009. View